Has Alok Pant, MD received payments from drug or device companies?

Yes. Drug and device makers reported $817 in general payments to Alok Pant, MD across 47 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alok Pant, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alok Pant, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alok Pant, MD

Internal Medicine · Shreveport, LANPI 1578875084

Payments from drug & device makers

$817in general payments, 2019–2025

Across 47 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$190
E.r. Squibb & Sons, L.L.C.$174
Novo Nordisk$131
Exact Sciences$125
Dexcom, Inc.$62
Pfizer$38
plus $97 from 3 others

What the payments were for

Food & beverage$817100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	11	$190
E.r. Squibb & Sons, L.L.C.	13	$174
Novo Nordisk	6	$131
Exact Sciences	7	$125
Dexcom, Inc.	3	$62
Pfizer	2	$38
Bayer	2	$37
Lilly USA, LLC	2	$34
Pharmacosmos Therapeutics Inc.	1	$25

How this compares

$817 in reported general payments places this provider in the 60th percentile of 1,528 internal medicine providers in Louisiana.

See all internal medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024

$30,675

Medicare patients

268

Services billed

335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	14	$23,387
Diclofenac Sodium	17	$611
Warfarin Sodium	64	$488
Atorvastatin Calcium	56	$431
Nifedipine ErNifedipine	27	$362
Albuterol Sulfate HfaAlbuterol Sulfate	11	$336
Pantoprazole Sodium	23	$158
Rosuvastatin Calcium	20	$129
Lisinopril	33	$128
Metformin Hcl	17	$116
Carvedilol	23	$115
Amlodipine Besylate	36	$103
Losartan Potassium	21	$91
Hydrochlorothiazide	23	$90
Hydralazine Hcl	13	$60

Paid to pharmacies, not to this prescriber.

Other internal medicine in Shreveport

Deepika RallaShreveport$261K
Maliha AgloriaShreveport$181K
Bharat SachdevaShreveport$165K
Rajan KhannaShreveport$59K
Ishak MansiShreveport$53K
Wendell WallShreveport$25K
Attila BaloghShreveport$18K
Ammar AlqaidShreveport$18K
William SmithNew Orleans$50.5M
Robert JeanfreauMetairie$13.4M

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →